Biogen Inc. (IDP.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 02:07PM CEST. Market open.
| Previous close | 207.10 |
| Open | 206.60 |
| Bid | 207.60 x 10000 |
| Ask | 208.80 x 10000 |
| Day's range | 206.60 - 209.80 |
| 52-week range | 178.30 - 262.20 |
| Volume | |
| Avg. volume | 27 |
| Market cap | 30.701B |
| Beta (5Y monthly) | -0.04 |
| PE ratio (TTM) | 28.31 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Investor's Business Daily
Biden Just Knocked Eli Lilly Stock Off Its Pedestal — Is It A Buy Or A Sell?
Is Eli Lilly stock a buy or a sell after Joe Biden called out Lilly and Novo Nordisk for high drug prices? Is LLY stock a buy or a sell?
- Investor's Business Daily
Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.
- Insider Monkey
Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
ClearBridge Investments, an investment management company, released its “ClearBridge Value Equity Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The strategy outperformed the Russell 1000 Value Index in the first quarter. On an absolute basis, the strategy has gained 9 out of eleven sectors it invested in during […]
© 2024 Yahoo. All rights reserved.